Muscular dystrophy with truncated dystrophin in a family of Japanese Spitz dogs

Journal of the Neurological Sciences

Volumn 217, Issue 2, 2004, Pages 143-149

  Jones, Boyd R ^a   Brennan, Sheila ^a   Mooney, Carmel T ^a   Callanan, John J ^a   McAllister, Hester ^a   Guo, Ling T ^b   Martin, Paul T ^c   Engvall, Eva ^b   Shelton, G Diane ^d  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Canine; Dystrophin; Japanese Spitz; Muscle; Myopathy

Indexed keywords

DYSTROPHIN; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOG DISEASE; DYSPHAGIA; EXERCISE TOLERANCE; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYALGIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0346727235     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2003.09.002     Document Type: Article

References (34)

1. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
2. De Visser M., de Voogt W.G., la Riviere G.V. The heart in Becker muscular dystrophy, fascioscapulohumeral dystrophy, and Bethlem myopathy. Muscle Nerve. 15:1992;591-596.
3. England S.B., Nicholson L.V.D., Johnson M.A., Forrest D.R.et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 343:1990;180-182.
4. Straub V., Campbell K.P. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10:1997;168-175.
5. Wewer U.M., Engvall E. Merosin/laminin-2 and muscular dystrophy. Neuromuscul. Disord. 6:1996;409-418.
6. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell. 80:1995;675-679.
7. Cooper B.J., Valentine B.A., Wilson D.F.et al. Canine muscular dystrophy: confirmation of X-linked inheritance. J. Hered. 79:1988;405-408.
8. Kornegay J.E. Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve. 11:1988;1056-1064.
9. Sharp N., Kornegay J., Van Camp S.et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics. 13:1992;115-121.
10. Winand N., Pradham D., Cooper B. Molecular characterization of severe Duchenne-type dystrophy in a family of Rottweiler dogs. Molecular mechanisms of neuromuscular disease. 1994;Muscular Dystrophy Association, Tucson, AZ.
11. Schatzberg S.J., Olby N.J., Breen M.et al. Molecular analysis of a spontaneous dystrophin "knockout" dog. Neuromuscul. Disord. 9:1999;289-295.
12. Valentine B.A., Winand N.J., Pradhan D.et al. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am. J. Med. Gen. 42:1992;352-356.
13. Van Ham L.M.L., Desmidt M., Tshamata M.et al. Canine X linked muscular dystrophy in Belgian Groendaeler Shepherds. J. Am. Anim. Hosp. Assoc. 29:1993;570-574.
14. Van Ham L.M.L., Roels S., Hoorens J.K. Congenital dystrophy-like myopathy in a Brittany spaniel puppy. Prog. Vet. Neurol. 6:1995;135-138.
15. Wentick G.H., Vanderlinde-Sipman J.S., Meijer A.E.F.H.et al. Myopathy with a possible recessive x-linked inheritance in a litter of Irish terriers. Vet. Pathol. 9:1972;328-349.
16. Paola J.P., Podell M., Shelton G.D. Muscular dystrophy in a miniature Schnauzer. Prog. Vet. Neurol. 4:1993;14-18.
17. Wetterman C.A., Harkin K.R., Cash W.C.et al. Hypertrophic muscular dystrophy in a young rat terrier. J. Am. Vet. Med. Assoc. 216:2000;878-881.
18. Braund K.G. Diagnostic techniques. Chapter 4 Clinical syndromes in veterinary neurology. 1994;396 Mosby, St. Louis.
19. Callis EM. Bone. In: Bancroft JD, Gamble M eds, The Theory and Practice of Histological Techniques, vol. 202. 5th Ed. London: Churchill Livingstone. p. 293.
20. Dubowitz V. Muscle biopsy. Dubowitz V. Muscle biopsy: a practical approach. 2nd ed. 1985;19-40 Bailliere Tindall, Philadelphia.
21. Liu L.A., Engvall E. Sarcoglycan isoforms in skeletal muscle. J. Biol. Chem. 274:1999;38171-38176.
22. Leivo I., Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc. Natl. Acad. Sci. U. S. A. 85:1988;1544-1548.
23. Shelton G.D., Engvall E. Muscular dystrophies and other inherited myopathies. Shelton G.D. The veterinary clinics of North America. Neuromuscular Diseases. vol. 32:2002;103-124 W.B. Saunders Co. Philadelphia.
24. Engel A.E., Yamamoto M., Fischbeck K.H. Dystrophinopathies. Engel A.E., Franzini-Armstron C. Myology. 2nd ed. 1994;1144 McGraw-Hill, New York.
25. Specht L., Shapiro F. Boys with Duchenne and Becker muscular dystrophy are clinically indistinguishable at presentation (abstract). Ann. Neurol. 28:1990;443.
26. Banks W.J. Digestive system 1 - alimentary canal. Applied veterinary histology. 3rd ed. 1993;336 Mosby, St. Louis.
27. Bushby K.M., Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy: I. Natural history. J. Neurol. 240:1993;98-104.
28. Valentine B.A., Blue J.T., Shelly S.M., Cooper B.J. Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog. J. Vet. Intern. Med. 4:1990;140-143.
29. Arahata K., Beggs A.H., Honda H., Ito S., Ishiura S., Tsukahara T.et al. Preservation of the C-terminus of the dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J. Neurol. Sci. 101:1991;148-156.
30. Anderson L.V.B. Dystrophinopathies. Karpati G. Structural and molecular basis of skeletal muscle diseases. 2002;6-23 ISN Neuropath Press, Basel.
31. Hori S., Ohtani S., Thi Man N., Morris G.E. The N-terminal half of dystrophin is protected from proteolysis in situ. Biochem. Biophys. Res. Commun. 209:1995;1062-1067.
32. Sakamoto M., Yuasa K., Yoshimura M., Yokota T., Ikemoto T., Suzuki M.et al. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem. Biophys. Res. Commun. 293:2002;1265-1272.
33. Harper S.Q., Hauser M.A., DelloRusso C.et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8:2002;253-261.
34. Leibovitz S., Meshorer A., Fridman Y., Wieneke S., Jockusch H., Yaffe D.et al. Exogenous Dp71 is a dominant negative competitor of dystrophin in skeletal muscle. Neuromuscul. Disord. 12:2002;836-844.